HemoGAD Technologies

medical devices

About

At Hemogad we are committed to improving the outcome and quality of life for Haemochromotosis sufferers through medical research and to providing useful information about Genetic Haemochromotosis (GH) and Hereditary Haemochromatosis (HH) and researching ways to improve your health outcome as a Haemochromotosis sufferer. Haemochromotosis is a genetic condition characterised by iron overload which, untreated, causes irreversible organ damage and results in chronic conditions including cirrhosis, diabetes, heart arrhythmia and arthritis. HH has also been linked to Alzheimer's (Florey Institute in Melbourne and the CSIRO), due to elevated levels of iron in the brain. Diagnosis often comes after a patient has developed one, or more, of these conditions, by which time a negative impact on quality of life has already occurred. The delay is due to clinical diagnosis requiring a full blood count confirmed by genetic screening; this is expensive and time consuming for an overstretched and under-funded NHS.

Technologies

Outlook Microsoft Office 365 GoDaddy Hosting Mobile Friendly McAfee Google Font API WordPress.org YouTube Render AI Remote

Keywords

medical equipment manufacturing salivary ferritin research salivary ferritin as biomarker home testing device biotechnology medical devices salivary ferritin validation non-invasive monitoring healthcare equipment & supplies b2c genetic screening salivary ferritin assay development d2c home test for iron levels iron overload management salivary ferritin blood test alternative medical device research hereditary hemochromatosis healthtech iron deficiency anemia saliva-based test nhs blood donation e-commerce salivary ferritin assay patient self-monitoring iron level monitoring medical equipment and supplies manufacturing healthcare technology healthcare

Location

105 Constable Road, Corby, England, United Kingdom, NN18 0RT

Related Companies

Companies in the same industry